Discover 1,108 paid clinical trials in Hartford, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,108
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
for
Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma,
Location: New Haven CT, New York NY, Rochester NY, Detroit MI,
Sponsor: Panbela Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05254171
Phase2, Phase3, Recruiting
A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: New Haven CT, Madison WI, Houston TX, Seattle WA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06625593
Phase1, Recruiting
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Relapsed and/or Refractory Multiple Myeloma
Location: New Haven CT, Boston MA, New York NY, Nashville TN,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06153251
Phase1, Recruiting
Study of AVZO-021 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor, HR+/HER2- Breast Cancer,
Location: New Haven CT, Mineola NY, New York NY, Philadelphia PA,
Sponsor: Avenzo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05867251
Phase1, Phase2, Recruiting
Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors
for
Advanced Refractory Solid Tumors,
Location: New Haven CT, Ohio City OH, Michigan Center MI,
Sponsor: Cosmo Technologies Ltd
Sex: All
Age: 18+
Code: NCT03863145
Early_phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
QTX3034 in Patients With KRAS G12D Mutation
for
Solid Tumors
Location: New Haven CT, The Bronx NY, New York NY, Fairfax VA,
Sponsor: Quanta Therapeutics
Sex: All
Age: 18+
Code: NCT06227377
Phase1, Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumor, Melanoma, Head and Neck Cancer,
Location: New Haven CT, New York NY, Baltimore MD, Buffalo NY,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06172478
Phase2, Recruiting
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
for
Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary,
Location: New Haven CT, Providence RI, New York NY, Baltimore MD,
Sponsor: Volastra Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05902988
Phase1, Phase2, Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: New Haven CT, Boston MA, New York NY, Montreal,
Sponsor: Servier Bio-Innovation LLC
Sex: All
Age: 18+
Code: NCT06127407
Phase3, Recruiting
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
for
Solid Tumors
Location: New Haven CT, Boston MA, New York NY, Philadelphia PA,
Sponsor: ORIC Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05315700
Phase1, Phase2, Recruiting
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
for
Neoplasm, Cancer, Malignant Tumors
Location: New Haven CT, Boston MA, Fairfax VA, Grand Rapids MI,
Sponsor: Compugen Ltd
Sex: All
Age: 18+
Code: NCT06759649
Phase1, Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Location: New Haven CT, Boston MA, New York NY, Philadelphia PA,
Sponsor: PMV Pharmaceuticals, Inc
Sex: All
Age: 12+
Code: NCT04585750
Phase1, Phase2, Recruiting
ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
for
Advanced Solid Tumor, PDAC, HNSCC
Location: New Haven CT, Boston MA, New York NY, St Louis MO,
Sponsor: Adcendo ApS
Sex: All
Age: 18+
Code: NCT06597721
Phase1, Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: New Haven CT, Albany NY, New York NY, Boston MA,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase2, Phase3, Recruiting
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
for
Cancer, Cancer Central Nervous System, Cancer Thoracic,
Location: New Haven CT, Pittsburgh PA, Dallas TX, Duarte CA,
Sponsor: RefleXion Medical
Sex: All
Age: 0+
Code: NCT05406167
Recruiting
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: New Haven CT, Boston MA, New Brunswick NJ, Baltimore MD,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06385080
Phase1, Phase2, Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: New Haven CT, New Brunswick NJ, Philadelphia PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136650
Phase3, Recruiting
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
for
Generalized Myasthenia Gravis
Location: New Haven CT, Foxborough MA, New York NY, Totowa NJ,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT07039916
Phase3, Recruiting
RCT of Cervical Ripening Double Ballon Catheter Prior to Dilation and Evacuation.
for
Cervical Preparation Prior to Dilation and Evacuation
Location: New Haven CT
Sponsor: Yale University
Sex: Female
Age: 18+
Code: NCT07200115
Recruiting
New
Exploring the Utility of [18F]3F4AP for Demyelination Imaging